Time to Benefit Estimated for Intensive BP Control to Prevent Stroke

WEDNESDAY, Feb. 9, 2022 (HealthDay News) -- About 1.7 years of more intensive hypertensive treatment would be needed to prevent one stroke per 200 older adults, according to research published online Feb. 9 in the Journal of the American Geriatrics Society.
Vanessa S. Ho, from California Northstate University in Elk Grove, and colleagues conducted a meta-analysis to estimate the time to benefit (TTB) for stroke prevention after initiation of more intensive hypertension treatment in adults aged 65 years or older. Data were abstracted from randomized controlled trials comparing standard to more intensive treatment groups among older adults. Data were included from nine trials, with 38,779 individuals.
The researchers found that for 200 persons receiving more intensive hypertensive treatment, 1.7 years were required to prevent one stroke. Across studies, there was heterogeneity; longer TTB was seen for studies focusing on tighter systolic blood pressure (SBP) control (SBP <150 mm Hg). In the SPRINT study (baseline SBP, 140 mm Hg; achieved SBP, 121 mm Hg), the TTB was 59 years to avoid one stroke for 200 treated patients.
"These results suggest that almost all older adults with hypertension would benefit from treatment," the authors write. "For older adults with relatively well-controlled hypertension (i.e., SBP <150 mm Hg), the TTB to prevent one stroke for 200 persons treated is likely substantially longer than 1.7 years."
Related Posts
Psychologists’ Group Issues First Guidelines on Teens’ Use of Social Media
TUESDAY, May 9, 2023 (HealthDay News) -- It’s easy for kids to get drawn into...
More Young Americans Are Dying of Heart Failure
THURSDAY, July 28, 2022 (HealthDay News) -- A growing number of younger American...
Biden Plan Will Tackle Mental Health Crisis in America
FRIDAY, March 4, 2022 (HealthDay News) -- President Joe Biden has announced a...
Una vacuna terapéutica contra el cáncer mejora la supervivencia de las personas con un melanoma avanzado
LUNES, 17 de abril de 2023 (HealthDay News) -- Una vacuna experimental diseñada...
